Psychosis Associated With Tacrolimus at Therapeutic Serum Levels

Prim Care Companion CNS Disord. 2022 Dec 8;24(6):21cr03201. doi: 10.4088/PCC.21cr03201.

Authors

N A Uvais^{1

2}, Benil Hafeeq³, Jyotish Chalil Gopinathan³, Feroz AzIz³

Affiliations

¹ Department of Psychiatry, Iqraa International Hospital and Research Centre, Calicut, Kerala, India.
² Corresponding author: N. A. Uvais, MBBS, DPM, Iqraa International Hospital and Research Centre, Malaparamba, Calicut, Kerala, 673009, India ([email protected]).
³ Department of Nephrology, Iqraa International Hospital and Research Centre, Kozhikode, Kerala, India.

PMID: 36508727
DOI: 10.4088/PCC.21cr03201

No abstract available

MeSH terms

Humans
Immunosuppressive Agents / adverse effects
Kidney Transplantation*
Psychotic Disorders* / drug therapy
Tacrolimus / adverse effects

Substances

Tacrolimus
Immunosuppressive Agents